New treatment shows promise...

1 Posts | Page(s): 1 

New treatment shows promise...

by Mike_in_Co on Thu Nov 18, 2010 09:12 PM

Quote | Reply

I thought this might benefit some people:

The American Society of Clinical Oncology recently published its Clinical Cancer Advances 2010 and hailed a new drug combination, FOLFIRINOX as being the most significant advance for pancreatic cancer this year.


The study’s authors, presenting at ASCO 2010, reported 48% of patients on FOLFIRINOX were alive after 1 year compared to 20% on the gemcitabine arm and, for the first time in a study involving patients with metastatic pancreatic cancer, a median overall survival of 11.1 months was obtained on the FOLFIRINOX arm.



1 Posts | Page(s): 1 
Subscribe to this message board discussion

Latest Messages

View More

We care about your feedback. Let us know how we can improve your CancerCompass experience.